| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 03.02.
| The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | | 89 | PR Newswire |
| CHICAGO, Feb. 3, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | |
| 03.02.
| 2012 Economic Outlook - Report Highlights Red Hat, Inc. and Medtronic, Inc. | | 21 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/03/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Red Hat, Inc. (NYSE: RHT) and Medtronic, Inc. (NYSE: MDT). Gain market insight with full analysis...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Red Hat, Inc. and Medtronic, Inc. | |
| 01.02.
| Medtronic Announces First Patient Enrollment In IMPROVE HF Bridge Study | | 45 | AFX News |
| FRIDLEY (dpa-AFX) - Medtronic Inc. (MDT) announced the initiation and first
patient enrollment in a clinical study that will evaluate gaps in the
implementation of evidence-based treatment...
Mehr lesen zu:
Medtronic Announces First Patient Enrollment In IMPROVE HF Bridge Study | |
| 01.02.
| Medtronic (MDT) Enrolls First Patient in IMPROVE HF Bridge Study | | 2 | StreetInsider.com |
| 01.02.
| Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting | | 18 | Business Wire |
| IMPROVE HF Bridge Study Will Examine Specific Gaps in
Implementation of Guideline-Recommended Treatment in Heart Failure
Patients Post-Hospital Discharge
...
Mehr lesen zu:
Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting | |
| 01.02.
| What Medtronic Does With Its Cash | | 9 | Motley Fool |
| 30.01.
| Medtronic Says Data from Corevalue Demonstrates Positive Outcomes | | 1 | Benzinga.com |
| 30.01.
| Medtronic (MDT) Reports Positive Clinical Outcomes for CoreValve System Using Direct Aortic Approach | | - | StreetInsider.com |
| 30.01.
| Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve® System Using Direct Aortic Approach | | 55 | Business Wire |
| Multicenter Experience Demonstrates Surgical Approach, with Recent CE
Mark, is a Feasible Alternative for Transcatheter Aortic Valve
Implantation
...
Mehr lesen zu:
Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve® System Using Direct Aortic Approach | |
| 30.01.
| Medtronic Says FDA Approved DF4 High-Voltage Connector System | | 56 | AFX News |
| FRIDLEY (dpa-AFX) - Medtronic, Inc. (MDT) said that the FDA approved DF4
High-Voltage Connector System, a right ventricular lead and connector used with
implantable cardioverter defibrillators...
Mehr lesen zu:
Medtronic Says FDA Approved DF4 High-Voltage Connector System | |
| 30.01.
| Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices | | 8 | Business Wire |
| New System Builds On Sprint Quattro® Lead,
Adding to the Company's Portfolio of Innovative Technologies Proven to
Treat Heart Rhythm Disorders
...
Mehr lesen zu:
Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices | |
| 27.01.
| Medtronic Crosses Below its 10-day MA | | 1 | SmarTrend |
| 27.01.
| Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami Instruments | | 40 | Business Wire |
| Medtronic, Inc. (NYSE: MDT) today announced that it has entered into an
exclusive distribution agreement with Miami Instruments, LLC – a company
focused on the design...
Mehr lesen zu:
Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami Instruments | |
| 26.01.
| Medtronic Judge Denies Nuvasive Claim Patent is Invalid | | 3 | Benzinga.com |
| 26.01.
| Is Medtronic's Growth for Real? | | 9 | Motley Fool |
| 26.01.
| The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and CA | | 52 | PR Newswire |
| CHICAGO, Jan. 26, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and CA | |
| 26.01.
| Medtronic (MDT) Injunction Against NuVasive (NUVA) Tentatively Denied in San Diego Court | | 2 | StreetInsider.com |
| 25.01.
| Medtronic and Guided Therapeutics Poised for Growth / Five Star Equities Provides Stock Research on Medtronic & Guided Therapeutics | | 25 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/25/12 -- The medical device sector has been seeing increased investor interest over the last year. According to a recent report from Dow Jones, venture investments...
Mehr lesen zu:
Medtronic and Guided Therapeutics Poised for Growth / Five Star Equities Provides Stock Research on Medtronic & Guided Therapeutics | |
| 24.01.
| Medtronic Completes Enrolling Extreme Risk Patient Group In CoreValve U.S. Trial | | 45 | AFX News |
| FRIDLEY (dpa-AFX) - Medtronic Inc. (MDT) said Tuesday it has completed
patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal
Trial. The medical devices company also...
Mehr lesen zu:
Medtronic Completes Enrolling Extreme Risk Patient Group In CoreValve U.S. Trial | |
| 24.01.
| Medtronic (MDT) gets FDA okay for extended investigation of CoreValve(R) trial | | 2 | StreetInsider.com |
